Fresno

FDA health panel endorses Merck COVID-19 pill, paving way for US authorization of 1st at-home drug for virus – Fresno, California

Fresno, California 2021-11-30 17:18:33 –

Washington-Tuesday’s Commission of U.S. Health Advisers narrowly supports the benefits of the carefully watched COVID-19 pill from Merck and approves the first drug Americans can take at home to treat the virus. Ready for the possibility.

A committee of the Food and Drug Administration voted 13-10 that the benefits of the drug outweigh its risks, including potential birth defects when used during pregnancy.

The group’s recommendations came after hours of discussion about the modest benefits of the drug and potential safety issues. Experts who support treatment emphasized that pregnant women should not use it and called on the FDA to recommend additional precautions, including pregnancy tests for women before using the drug. ..

The group’s vote specifically favored drugs for adults with mild to moderate COVID-19 facing maximum risk, including conditions such as obesity, asthma, and old age.

The FDA is not bound by the panel’s recommendations and is expected to make its own decisions by the end of the year.

FDA approval of the drug molnupiravir could be a major step in viral treatment. It gives the doctor the first medicine that the patient can prescribe for himself, reduces the burden on the hospital and helps control death.

Pills are already licensed in the UK

Related: Pfizer enables broader global access to experimental COVID-19 antivirals

The video above is from a previous report.

Copyright © 2021 AP communication. all rights reserved.



FDA health panel endorses Merck COVID-19 pill, paving way for US authorization of 1st at-home drug for virus Source link FDA health panel endorses Merck COVID-19 pill, paving way for US authorization of 1st at-home drug for virus

Back to top button